CAR T-Cell Therapy: Durable Responses Reshape Cancer Care Didier Dillen

https://www.medscape.com/viewarticle/car-t-cell-therapy-durable-responses-reshape-cancer-care-2026a1000z1j?src= Chimeric antigen receptor (CAR) T-cell therapy is a reshaping treatment for several hematologic malignancies, with clinical data showing improved outcomes in aggressive lymphoma and durable responses in some patients with multiple myeloma. At the 60th Congress of the Postgraduate Education Days of the Association des Médecins anciens étudiants de l’Université libre de Bruxelles (AMUB) in 2026, Marie Vercruyssen, MD, Department of Hematology, Jules Bordet Institute, Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium, presented recent advances in therapy and discussed its emerging...